We partner as your commercial team and execute — from initial implementation planning through to in-market operations and scale.

A Valthera engagement follows a consistent structure. We start by producing a market entry and revenue generation implementation plan — a detailed, commercially validated blueprint for your European entry.

From there, we work as your commercial operations team to deliver it — coordinating execution, building infrastructure, and driving performance in-market.

The depth and duration of the planning phase depends on your market footprint and internal capability, but the principle remains the same: we are accountable for execution, not just advice.

Market Entry Implementation Plan
The foundation of every Valthera engagement

The implementation plan is the foundation of every Valthera engagement — and the starting point before any execution begins. We build a commercially grounded, country-specific plan that defines where to play, what to sell, and how to win. It is designed to be executed, not presented.

  • Market attractiveness and entry complexity mapped by country
  • Country selection, prioritisation, and staged entry sequencing
  • Competitive landscape and first-mover window assessment
  • Commercial model selection and GTM architecture per market
  • Integrated execution timeline: regulatory, commercial, and supply milestones
Portfolio–Market Fit Validation
Validating commercial viability before execution

We validate which molecules have genuine commercial viability in which markets — and build the prioritisation logic that prevents capital being deployed against the wrong products in the wrong sequence. This feeds directly into the implementation plan and sets the commercial case for each country entry.

  • Molecule-level commercial viability assessment by target market
  • First-to-LOE timing and market window analysis
  • COGS competitiveness against local tender and pricing benchmarks
  • Therapeutic area prioritisation aligned to country-level demand dynamics
Go-to-Market Build & Launch Execution
Designing and operating the commercial model

We build the go-to-market model and then run the launch. This means designing the right commercial architecture for each market — and staying embedded to implement it. Channel structure, customer model, commercial footprint, and launch sequencing are built and operated by us, not handed over as a document.

  • Channel model build: direct KAM, distributor-led, or hybrid — designed and implemented
  • Customer model execution: HCP-facing, pharmacy-facing, or tender-facing operations
  • Commercial footprint structuring: own entity, contracted, or distribution partner
  • GTM cost modelling, investment staging, and in-market performance management
Partner Selection & Onboarding
Building and managing your distribution network

The wrong distribution partner can set a market entry back by two or more years. We select, qualify, negotiate, and onboard distribution, co-promotion, and tender management partners — and build the performance framework to manage them once in place.

  • Distributor landscape mapping and partner shortlisting by country and therapeutic area
  • Partner due diligence and qualification against defined commercial criteria
  • Commercial term negotiation and agreement structuring
  • Partner onboarding, launch coordination, and ongoing performance management
Business Development Execution
Identifying and closing commercial opportunities

We identify, pursue, and close BD opportunities — in-licensing, out-licensing, and commercial partnership agreements. We work as an extension of your BD team rather than an outside adviser: building target lists, managing outreach, and negotiating terms through to execution.

  • In-licensing, out-licensing and exclusive distribution target identification and outreach
  • Commercial deal structuring and term sheet development
  • Due diligence support across commercial, market access, and GTM dimensions
  • Co-promotion and co-commercialisation partnership framework build and execution
Regulatory–Commercial Integration
Aligning regulatory and commercial timelines

Regulatory timelines built in isolation from commercial plans are one of the most common and costly causes of European launch failure. We integrate regulatory and commercial workstreams — building a single execution timeline and managing cross-functional dependencies so launch windows are not missed.

  • MA filing strategy integrated with launch windows and tender calendars
  • Regulatory-commercial dependency mapping and milestone ownership
  • Country-specific reimbursement and market listing timeline execution
  • Launch readiness management across regulatory, supply, and commercial functions